![]() A significant drop in share price: Finally, Aurora Cannabis shares have had a difficult few months recently with a loss of over 90% of their value since 2019.Increasing competition: Aurora Cannabis is facing increasing and aggressive competition from other Canadian and international companies, which reduces the chances of gaining market share.No dividend: of course, the absence of dividend paid to the shareholders of the group is another weak point of this action which can slow down the operations to the purchase.Negative analysts' expectations: analysts' opinions regarding the cannabis market are also relatively negative at the moment, notably due to strong pressure on prices.Negative EBITDA: the EBITDA group's operating result is still in losses for this last fiscal year and the group still cannot generate a margin.Disappointing results in 2021: the fiscal year 2021 has been rather disappointing for analysts and investors who follow this stock with results below expectations and a significant decline in sales over the four quarters.If Aurora Cannabis is currently benefiting from good elements that are favourable to the rise of its share, some elements are more moderate and indicate more of a decline in this value including: By 2026, this market is expected to be worth over $57 billion. A significant increase in the global market: the global cannabis market is still growing at an estimated rate of 20% per year for the medical cannabis segment alone.House of Representatives approved the SAFE Banking Act, which now allows banks to work with cannabis businesses without risking penalties. More flexible banking regulations in the U.S.: The U.S.A recovery in the recreational cannabis sector: on the other hand, the recreational cannabis segment is on the verge of recovery thanks to an acceleration of new store openings as well as a strong increase in consumer demand.Largest regulated market: Canada, where Aurora Cannabis operates, is also the second country in the world after Uruguay to have fully legalized cannabis and is currently the largest federally regulated market in the world.The group continues to develop this high margin market. An increase in the revenue of the medical branch: the medical branch of the Aurora Cannabis group is currently and since 2021 experiencing significant growth internationally.When we look at the macro and microeconomic situation of the company Aurora Cannabis, several elements currently seem to support a rise in the price of this value with the following points: Save almost $500 in fees using the code: 50TRADESFREE Sign-up Why Aurora shares could go up: ![]()
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |